Bank of America’s CalciMedica CALC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,027
Closed -$59.5K 5891
2025
Q4
$59.5K Sell
9,027
-5
-0.1% -$20 ﹤0.01% 5784
2025
Q3
$27.8K Sell
9,032
-8
-0.1% -$23 ﹤0.01% 6996
2025
Q2
$14.5K Buy
9,040
+17
+0.2% +$29 ﹤0.01% 7119
2025
Q1
$17.2K Buy
9,023
+4
+0% +$10 ﹤0.01% 7008
2024
Q4
$31.9K Sell
9,019
-191
-2% -$670 ﹤0.01% 6738
2024
Q3
$40.8K Buy
9,210
+202
+2% +$888 ﹤0.01% 6601
2024
Q2
$35.7K Buy
9,008
+8,501
+1,677% +$42.8K ﹤0.01% 6597
2024
Q1
$2.11K Hold
507
﹤0.01% 7121
2023
Q4
$1.45K Buy
507
+477
+1,590% +$1.38K ﹤0.01% 7157
2023
Q3
$80 Buy
30
+29
+2,900% +$96 ﹤0.01% 7478
2023
Q2
$4 Buy
+1
New +$4 ﹤0.01% 7611
2023
Q1
Sell
-3
Closed -$22 7837
2022
Q4
$22 Buy
+3
New +$34 ﹤0.01% 7965
2022
Q1
Sell
-8
Closed 8282
2021
Q4
$0 Buy
+8
New +$311 ﹤0.01% 8239
2021
Q3
Sell
-87
Closed -$7K 8120
2021
Q2
$7K Sell
87
-588
-87% -$38.6K ﹤0.01% 7368
2021
Q1
$53K Buy
675
+567
+525% +$170K ﹤0.01% 6612
2020
Q4
$44K Buy
+108
New +$31.9K ﹤0.01% 6368

Other funds holding CALC

Bank of America's CALC Position: Q1 2026 in Review

Bank of America sold out of CalciMedica (CALC) in Q1 2026, closing a stake of 9,027 shares — an estimated $59.5K sold.

Bank of America first reported a position in CALC in Q4 2020 and held it in 16 quarters. The position peaked at $59.5K in Q4 2025. 27 funds tracked by Wall St. Rank hold CALC as of Q1 2026.

  • Bank of America reported no remaining CalciMedica position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 9,027 CalciMedica shares in Q1 2026, an estimated $59.5K.
  • Bank of America first reported a position in CalciMedica in Q4 2020 and held it in 16 quarters.
  • Bank of America's CalciMedica position peaked at $59.5K in Q4 2025.
  • 27 funds tracked by Wall St. Rank held CalciMedica as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.